Cost effectiveness of rotavirus vaccination in Australia

Australian and New Zealand Journal of Public Health

Volumn 23, Issue 6, 1999, Pages 611-616

  Carlin, John B ^b   Jackson, Terri ^a   Lane, Lisa ^b   Bishop, Ruth F ^b   Barnes, Graeme L ^b  

^a MONASH UNIVERSITY   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; AUSTRALIA; CHILD; COST EFFECTIVENESS ANALYSIS; DRUG COST; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; VACCINATION; VIRUS INFECTION;

EID: 0033371785     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1467-842X.1999.tb01546.x     Document Type: Article

References (21)

1. Glass RI, Kilgore PE, Holman RC, et al. The epidemiology of rotavirus diarrhea in the United States: Surveillance and estimates of disease burden. J Infect Dis 1996; 174(1 Suppl): S5-11.
2. Ryan MJ, Ramsay M, Brown D, et al. Hospital admissions attributable to rotavirus infection in England and Wales. J Infect Dis 1996; 174(1 Suppl): S12-18.
3. Ferson MJ. Hospitalisations for rotavirus gastroenteritis among children under five years of age in New South Wales. Med J Aust 1996; 164: 273-7.
4. Carlin JB, Chondros P, Masendycz P, et al. Rotavirus infection and rates of hospitalisation for acute gastroenteritis in young children in Australia, 1993-96. Med J Aust 1998; 169: 252-6.
5. Rennels MB, Glass RI, Dennehy PH, et al. Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines - report of the national multicenter trial. Pediatrics 1996; 97: 7-13.
6. Barnes GL, Lund JS, Adams L, et al. Phase 1 trial of a candidate rotavirus vaccine (RV3) derived from a human neonate. J Paediatr Child Health 1997; 33: 300-4.
7. Advisory Committee on Immunization Practices. Rotavirus vaccines for the prevention of rotavirus diarrhea in children: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1999; 48: 1-23.
8. Tucker AW, Haddix AC, Bresee JS, et al. Cost-effectiveness analysis of a rotavirus immunization program for the United States. J Am Med Assoc 1998; 279: 1371-6.
9. DATA. Version 3.0. Williamstown(Ma): TreeAge Software, 1996.
10. Parashar UD, Kilgore PE, Holman RC, et al. Diarrheal mortality in U.S. infants: Influence of birth weight on risk factors for death. Arch Pediatr Adolesc Med 1998; 152: 47-51.
11. Smith JC, Haddix AC, Teutsch SM, Glass RI. Cost-effectiveness analysis of a rotavirus immunization program for the United States. Pediatrics 1995; 96: 609-15.
12. Parashar UD, Holman RC, Bresee JS, et al. Epidemiology of diarrheal disease among children enrolled in four west coast health maintenance organisations. Pediatr Infect Dis J 1998; 17: 605-11.
13. Joensuu J, Koskenniemi R, Pang X-L, Vesikari T. Randomised placebo-controlled trial of rhesus-human reassortant rotavirus for prevention of severe rotavirus gastroenteritis. Lancet 1997; 350: 1205-9.
14. Perez-Schael I, Guntinas MJ, Perez M, et al. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. N Engl J Med 1997; 337: 1181-7.
15. Keusch GT, Cash RA. A vaccine against rotavirus - when is too much too much? N Engl J Med 1997; 337:1228-9.
16. Migasena S, Simasathien S, Samakoses R, et al. Simultaneous administration of oral rhesus-human reassortant tetravalent (RRV-TV) rotavirus vaccine and oral poliovirus vaccine (OPV) in Thai infants. Vaccine 1995; 13: 168-74.
17. Rennels MB. Influence of breast-feeding and oral poliovirus vaccine on the immunogenicity and efficacy of rotavirus vaccines. J Infect Dis 1996; 174(1 Suppl):S107-S111.
18. Gold MR, Siegel JE, Russell LB, Weinstein MC Cost Effectiveness in Health and Medicine. New York: Oxford University Press, 1996.
19. Liddle JLM, Burgess MA, Gilbert GL, et al. Rotavirus gastroenteritis: impact on young children, their families and the health care system. Med J Aust 1997; 167: 304-7.
20. Griffiths RI, Anderson GF, Powe NR, et al. Economic impact of immunization against rotavirus gastroenteritis. Arch Pediatr Adolesc Med 1995; 149: 407-14.
21. Takala AK, Koskenniemi E, Joensuu J, et al. Economic evaluation of rotavirus vaccinations in Finland: randomized, double-blind, placebo-controlled trial of tetravalent rhesus rotavirus vaccine. Clin Infect Dis 1998; 27: 272-82.